TOKYO -- The Japanese health ministry's expert board on Monday postponed a decision on whether to approve Fujifilm Holdings' Avigan for coronavirus treatment, opting to examine more evidence to determine its efficacy.
Coronavirus
Japan health ministry delays decision on Avigan for coronavirus
Authorities seek additional data before greenlighting Fujifilm flu drug